Synthesis characterization and biological evaluation of alginate nanoparticle for the targeted delivery of curcumin

Materials Science and Engineering C

Volumn 78, Issue , 2017, Pages 1125-1134

  Anirudhan, Thayyath Sreenivasan ^a   Anila, Manasa Mohan ^a   Franklin, Shainy ^a  

^a UNIVERSITY OF KERALA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELLS; CHEMOTHERAPY; CYTOLOGY; DISEASES; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; POLYETHYLENES;

BIOLOGICAL EVALUATION; CANCER CELL LINES; FLUORESCENCE IMAGE; OPTIMUM CONDITIONS; POLYETHYLENE IMINES; SELECTIVE DESTRUCTION; TARGETED DELIVERY; TARGETING LIGANDS;

SYNTHESIS (CHEMICAL);

ALGINIC ACID; CURCUMIN; FOLIC ACID; GLUCURONIC ACID; HEXURONIC ACID; MACROGOL DERIVATIVE; NANOPARTICLE; POLYETHYLENEIMINE;

HUMAN; TUMOR CELL LINE;

ALGINATES; CELL LINE, TUMOR; CURCUMIN; FOLIC ACID; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE;

EID: 85018967121     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2017.04.116     Document Type: Article

References (63)

1. [1] American Cancer Society, Colorectal Cancer Facts & Figures 2011–2013. 2011, American Cancer Society, Atlanta.
2. [2] http://globocan.iarc.fr/factsheets/cancers/colorectal.asp.
3. [3] Glehen, O., Kwiatkowski, F., Sugarbaker, P.H., Elias, D., Levine, E.A., Simone, M.D., Barone, R., Yonemura, Y., Cavaliere, F., Quenet, F., Gutman, M., Tentes, A.K., Lorimier, G., Bernard, J.L., Bereder, J.M., Porcheron, J., Gomez-Portilla, A., Shen, P., Deraco, M., Rat, P., Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J. Clin. Oncol. 22 (2004), 3284–3292.
4. [4] Moorthi, C., Manavalan, R., Kathiresan, K., J. Pharm. Pharm. Sci. 14 (2011), 67–77.
5. [5] Anirudhan, T.S., Binusreejayan, Rejeena, S.R., Synthesis and characterisation of chitosan based multilayer and pH sensitive co polymeric system for the targeted delivery of 5-fluorouracil, an in vitro study. Int. J. Polym. Mater. 63 (2014), 539–548.
6. [6] Arias, J.L., Drug targeting strategies in cancer treatment: an overview. Mini-Rev. Med. Chem. 11 (2011), 1–17.
7. [7] Yoo, Hyuk Sang, Park, Tae Gwan, Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin–PEG–folate conjugate. J. Control. Release 100:2 (2004), 247–256.
8. [8] Olivier, J.C., Huertas, R., Lee, H.J., et al. Synthesis of pegylated immunonanoparticles. Pharm. Res. 19 (2002), 1137–1143.
9. [9] Tang, H., Murphy, C.J., Zhang, B., Shen, Y., Van Kirk, E.A., Murdoch, W.J., Curcumin polymers as anticancer conjugates. Biomaterials 31:27 (2010), 7139–7149.
10. [10] Javvadi, P., Segan, A.T., Tuttle, S.W., Koumenis, C., The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Mol. Pharmacol. 73 (2008), 1491–1501.
11. [11] Hong, J.H., Ahn, K.S., Bae, E., Jeon, S.S., Choi, H.Y., The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo. Prostate Cancer Prostatic Dis. 9 (2006), 147–152.
12. [12] Bachmeier, B.E., Nerlich, A.G., Iancu, C.M., Cilli, M., Schleicher, E., VenÉ, R., The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell. Physiol. Biochem. 19 (2007), 137–152.
13. [13] Chadalapaka, G., Jutooru, I., Chintharlapalli, S., Papineni, S., Smith, R. III, Li, X., Curcumin decreases specificity protein expression in bladder cancer cells. Cancer Res. 68 (2008), 534–554.
14. [14] Chen, A., Xu, J., Johnson, A.C., Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene 25 (2005), 278–287.
15. [15] Anand, P., Kunnumakkara, A.B., Newman, R.A., Aggarwal, B.B., Bioavailability of curcumin: problems and promises. Mol. Pharm. 4:6 (2007), 807–818.
16. [16] Cheng, A.L., Hsu, C.H., Lin, J.K., Hsu, M.M., Ho, Y.F., Shen, T.S., Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21 (2001), 2895–2900.
17. [17] Feiffer, P.E., Hoehle, S.I., Walch, S.G., Riess, A., Solyom, A.M., Metzler, M., Curcuminoids from reactive glucuronides in vitro. J. Agric. Food Chem. 55 (2007), 538–544.
18. [18] Anand, P., Nair, H.B., Sung, B.K., Kunnumakkara, A.B., Yadav, V.R., Tekmal, R.R., Design of curcumin- loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem. Pharmacol. 79 (2010), 330–338.
19. [19] Bisht, S., Feldmann, G., Soni, S., Rajani, R., Karikar, C., Maitra, A., Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy. J. Nanobiotechnol. 5 (2007), 1–18.
20. [20] Shah, C.P., Mishra, B., Kumar, M., Priyadarsini, K.I., Bajaj, P.N., Binding studies of curcumin to polyvinyl alcohol/polyvinyl alcohol hydrogel and its delivery to liposomes. Curr. Sci. India 95 (2008), 1426–1432.
21. [21] Sahu, A., Kasoju, N., Goswami, P., Bora, U., Encapsulation of curcumin in pluronic block copolymer micelles for drug delivery applications. J. Biomater. Appl. 10 (2010), 1010–1018.
22. [22] Sahu, A., Bora, U., Kasoju, N., Goswami, P., Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomater. 4 (2008), 1752–1761.
23. [23] Zimmermann, U., Klöck, G., Federlin, K., Hannig, K., Kowalski, M., Bretzel, R.G., Production of mitogen-contamination free alginates with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis. Electrophoresis 13 (1992), 269–274.
24. [24] Klöck, G., Frank, H., Houben, R., Zekorn, T., Horcher, A., Siebers, U., Production of purified alginates suitable for use in immunoisolated transplantation. Appl. Microbiol. Biotechnol. 40 (1994), 638–643.
25. [25] Maeda, H., Wu, J., Sawa, T., Matsumura, Y., Hori, K., Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 65 (2000), 271–284.
26. [26] Chen, K.H., Ling, Y.Z., Cao, C., Li, X.Y., Wang, X.Y., Chitosan derivatives/reduced graphene oxide/alginate beads for small-molecule drug delivery. Mater. Sci. Eng. C 69 (2016), 1222–1228.
27. [27] Painter, T.J., Smidsrød, O., Haug, A., A computer study of the changes in composition-distribution occurring during random depolymerisation ofa binary linear heteropolysaccharide. Acta Chem. Scand. 22 (1968), 1637–1648.
28. [28] Hari, P.R., Chandy, T., Sharma, C.P., Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin. J. Microencapsul. 13 (1999), 319–329.
29. [29] Lin, Y.H., Liang, H.F., Chung, C.K., Chen, M.C., Sung, H.W., Physically crosslinked alginate/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs. Biomaterials 26 (2005), 2105–2113.
30. [30] E.R. Hayes, (1986) U.S. Patent No. 4,619,995.
31. [31] Suzuki, Y., Nishimura, Y., Tanihara, M., Suzuki, K., Nakamura, T., Shimizu, Y., Yamawaki, Y., Kakimaru, Y., Evaluation of a novel alginate gel dressing. J. Biomed. Mater. Res. 39 (1998), 317–322.
32. [32] Cheng, Han, Zhi, Jing-Ling, Zeng, Xuan, Jing, Yue, Zhang, Qian-Zheng, Zhuo, Ren-Xi, Targeted gene delivery mediated by folate-polyethylenimine-block-poly(ethylene glycol) with receptor selectivity. Bioconjug. Chem. 20 (2009), 481–487.
33. [33] Anirudhan, T.S., Manasa Mohan, A., Novel pH switchable gelatin based hydrogel for the controlled delivery of anticancer drug 5-fluorouracil. RSC Adv., 4, 2014, 12109.
34. [34] Anitha, A., Maya, S., Deepa, N., Chennazhi, K.P., Nair, S.V., Tamura, H., Efficient water-soluble biodegradable polymeric nanocarrier for the delivery of curcumin to cancer cells. Carbohydr. Polym. 83 (2011), 452–461.
35. [35] Suwantong, O., Opanasopit, P., Ruktanonchai, U., Supaphol, Pitt, Electrospun cellulose acetate fiber mats containing curcumin and release characteristic of the herbal substance. Polymer 48 (2007), 7546–7557.
36. [36] Chen, Y., Wu, Q., Zhang, Z., Yuan, L., Liu, X., Zhou, L., Preparation of curcumin loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules 17 (2012), 5972–5987.
37. [37] Greenwald, R.B., PEG drugs: an overview. J. Control. Release 74 (2010), 159–171.
38. [38] H. Joshi, S. Vangapandu, R. Anelja, Conjugates of noscapine and folic acid and their use in treating cancer. (2010) WO Patent WO/2010/083,104.
39. [39] Ogris, M., Brunner, S., Schüller, S., Kircheis, R., Wagner, E., PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 4 (1999), 595–605.
40. [40] Liu, W., Wen, S., Shen, M., Shi, X., Doxorubicin-loaded poly(lactic-co-glycolic acid) hollow microcapsules for targeted drug delivery to cancer cells. New J. Chem., 38, 2014, 3917.
41. [41] Yang, C.H., Hon, M.H., The effect of the degree of deacetylation of chitosan nanoparticles and its characterization and encapsulation efficiency on drug delivery. Polym.-Plast. Technol. Eng. 49 (2010), 1292–1296.
42. [42] Jackson, W.A., Fulton, D.A., Making polymeric nanoparticles stimuli-responsive with dynamic covalent bonds. Polym. Chem., 4, 2013, 31.
43. [43] Abdelwahed, G., Degobert, S., Stainmesse, H., Fessi, V., Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv. Drug Deliv. Rev., 58, 2011, 1688.
44. [44] Bapat, J.G., Ray, D.A., Savin, E.A., Hoff, D.L., Patton, B.S., Dynamic-covalent nanostructures prepared by Diels–Alder reactions of styrene-maleic anhydride-derived copolymers obtained by one-step cascade block copolymerization. Polym. Chem. 3 (2012), 3112–3120.
45. [45] Furqanmaulvi, V.T., Thakkar Soni, T.G., Gohe, M.C., Gandhi, T.R., Supercritical fluid technology: a promising approach to enhance the drug solubility. J. Pharm. Sci. Res. 4 (2009), 1–14.
46. [46] Chaubey, P., Patel, R.R., Mishra, B., Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis. Expert Opin. Drug Deliv. 11 (2014), 1163–1181.
47. [47] Gonzalez-Mira, E., Egea, M.A., Souto, E.B., Calpena, A.C., García, M.L., Optimizingflurbiprofen-loaded NLC by central composite factorial design for oculardelivery. Nanotechnology 22 (2011), 5–11.
48. [48] Chan, J.M., Zhang, L., Yuet, K.P., Liao, G., Rhee, J.W., Langer, R., PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials 30 (2009), 1627–1634.
49. [49] Cho, K., Wang, X., Nie, S., Shin, D.M., Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res. 14 (2008), 1310–1316.
50. [50] Moghimi, S., Szebeni, J., Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 42 (2003), 463–478.
51. [51] Karria, Veera Venkata Satyanarayana Reddy, Kuppusamya, Gowthamarajan, Talluria, Siddhartha Venkata, Mannemalab, Sai Sandeep, et al. Curcumin loaded chitosan nanoparticles impregnated intocollagen-alginate scaffolds for diabetic wound healing. Int. J. Biol. Macromol. 93 (2016), 1519–1529.
52. [52] Boussif, O., A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U. S. A. 92 (1995), 7297–7301.
53. [53] Wang, Y.J., Pan, M.-H., Cheng, A.-L., Lin, L.-I., Ho, Y.-S., Hsieh, C.-Y., Lin, J.-K., Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 15 (1997), 1867–1876.
54. [54] Ritger, P.L., Peppas, N.A., A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Control. Release 5 (1987), 23–36.
55. [55] Costa, P., Lobo, J.M.S., Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 13 (2001), 123–133.
56. [56] Lara, M.G., Bentley, M.V., Collett, J.H., In vitro drug release mechanism and drug loading studies of cubic phase gels. Int. J. Pharm. 293 (2005), 241–250.
57. [57] Chen, L., Remondetto, G., Rouabhia, M., Subirade, M., Kinetics of the breakdown of cross-linked soy protein films for drug delivery. Biomaterials 29 (2008), 3750–3756.
58. [58] Kaul, G., Amiji, M., Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery. Pharm. Res. 19 (2002), 1062–1068.
59. [59] Anirudhan, T.S., Sandeep, S., Divya, P.L., Synthesis and characterization of maleated cyclodextrin-grafted-silylated montmorillonite for the controlled release and colon specific delivery of tetracycline hydrochloride. RSC Adv. 2 (2012), 9555–9564.
60. [60] Campbell, G., Jones, T.A., Foulkes, W.D., Trowsdale, Folate-binding protein is a marker for ovarian cancer. J. Cancer Res. Ther. 51 (2011), 5329–5338.
61. [61] Pan, D., Turner, J.L., Wooley, K.L., Folic acid conjugated nanostructured materials designed for cancer cell targeting. Chem. Commun. 9 (2003), 2400–2401.
62. [62] Finosh, G.T., Jayabalan, M., Influence of plasma protein-hydrogel interaction moderated by absorption of water on long-term cell viability in amphiphilic biosynthetic hydrogels. RSC Adv. 3 (2013), 24509–24520.
63. [63] Finosh, G.T., Jayabalan, M., Sankar, Vandana, Gopal, Raghu Kozhiparambil, Growth and survival of cells in biosynthetic poly vinyl alcohol–alginate IPN hydrogels for cardiac applications. Colloids Surf. B: Biointerfaces 107 (2013), 137–145.